Khatri, Amit <br/><br/>
Population Pharmacokinetics of the TNF-α and IL-17A Dual-Variable Domain Antibody ABT-122 in Healthy Volunteers and Subjects With Psoriatic or Rheumatoid Arthritis: Analysis of Phase 1 and 2 Clinical Trials.  [electronic resource] 

 -  Journal of clinical pharmacology  06 2018 
 - 803-813 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1552-4604 
<br/><br/><label>Standard No.: </label>10.1002/jcph.1068  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antirheumatic Agents--pharmacokinetics<br/>Arthritis, Psoriatic--drug therapy<br/>Arthritis, Rheumatoid--drug therapy<br/>Biological Availability<br/>Body Weight<br/>Double-Blind Method<br/>Female<br/>Healthy Volunteers<br/>Humans<br/>Immunoglobulins--pharmacology<br/>Interleukin-17--antagonists & inhibitors<br/>Male<br/>Metabolic Clearance Rate<br/>Methotrexate--therapeutic use<br/>Middle Aged<br/>Random Allocation<br/>Tumor Necrosis Factor-alpha--antagonists & inhibitors<br/>Young Adult